# EDGAR Filing Document

**Accession Number:** 0001708688
**File Stem:** 0001140361-25-023969
**Filing Date:** 2025-6
**Character Count:** 3731
**Document Hash:** e99ac04ab38ae42ecd63e09c1e97e567
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140361-25-023969.hdr.sgml**: 20250627

**ACCESSION NUMBER**: 0001140361-25-023969

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250627

**FILED AS OF DATE**: 20250627

**DATE AS OF CHANGE**: 20250627

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** InflaRx N.V.
- **CENTRAL INDEX KEY:** 0001708688
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** P7
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38283
- **FILM NUMBER:** 251086267

**BUSINESS ADDRESS:**
- **STREET 1:** WINZERLAER STR. 2
- **CITY:** JENA
- **STATE:** 2M
- **ZIP:** 07745
- **BUSINESS PHONE:** 49 3641 508180

**MAIL ADDRESS:**
- **STREET 1:** WINZERLAER STR. 2
- **CITY:** JENA
- **STATE:** 2M
- **ZIP:** 07745

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Fireman B.V.
- **DATE OF NAME CHANGE:** 20170606

------

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

### FORM 6-K

#### Report of Foreign Private

#### Issuer Pursuant to Rule

#### 13a-16 or 15d-16 under the

#### Securities Exchange Act

#### of 1934

#### For the month of June 2025
Commission File

Number: 001-38283

## InflaRx N.V.

#### Winzerlaer Str. 2

#### 07745 Jena,

#### Germany

#### (+49) 3641508180

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

------

#### OTHER INFORMATION
*Change in Certifying Accountant*

On June 26, 2025, InflaRx N.V. (the "Company") executed an engagement letter with KPMG AG Wirtschaftsprüfungsgesellschaft ("KPMG") to engage KPMG as its independent registered public accounting firm for the fiscal year ended December 31, 2025. In connection with this engagement, the Company ceased to engage EY GmbH & Co. KG Wirtschaftsprüfungsgesellschaft ("EY") as its independent registered public accounting firm. EY had served as the Company's independent registered public accounting firm since the fiscal year ended December 31, 2020. The change in independent registered public accounting firm follows the results of the Company's Annual General Meeting of Shareholders held, in accordance with Dutch law, on April 24, 2025, where the Company's shareholders voted to approve KPMG Accountants N.V. for the external audit of the Company's statutory annual accounts for the fiscal year ended December 31, 2025. The Company's decision to make the change in auditor was not due to any disagreement with EY. EY did not resign or decline to stand for re-election and EY's reports on the Company's financial statements as of and for the year ended December 31, 2024 and as of and for the year ended December 31, 2023 and on internal control over financial reporting as of December 31, 2024 and as of December 31, 2023 were not qualified and did not contain an adverse or disclaimer of opinion.

The Company will provide the additional disclosures in accordance with Item 16F regarding the predecessor auditor in its Form 20-F for the fiscal year ending December 31, 2025.

------

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: June 27, 2025 |  |  |
|  | **INFLARX N.V.** | **INFLARX N.V.** |
|  | By: | /s/ Niels Riedemann |
|  |  | Niels Riedemann |
|  |  | Chief Executive Officer |

---

------